Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections
Benson Ogunjimi1,2,3,4,5, Shen-Ying Zhang6,7,8, Katrine B Sørensen9,10,11
1Centre for Health Economics Research & Modeling Infectious Diseases, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
The Journal of Clinical Investigation
|August 8, 2017
Summary
Rare genetic mutations in POLR3A or POLR3C genes can lead to severe Varicella zoster virus (VZV) infections in children. These deficiencies impair the immune system's ability to detect viral DNA and produce interferon, increasing VZV disease risk.
Area of Science:
- Immunology
- Genetics
- Virology
Background:
- Varicella zoster virus (VZV) causes chickenpox but can rarely lead to severe, life-threatening illness in healthy individuals.
- The immunological underpinnings of severe VZV disease in immunocompetent hosts are not fully understood.
Purpose of the Study:
- To investigate the genetic and immunological basis for severe VZV infections in otherwise healthy children.
- To identify specific genetic defects that may predispose individuals to severe VZV disease.
Main Methods:
- Case study of four unrelated children with severe VZV infections (central nervous system or lung).
- Genetic analysis for mutations in POLR3A and POLR3C genes, which encode RNA polymerase III subunits.
- Immunological assays on patient leukocytes to assess interferon (IFN) induction and response to VZV infection.
- Functional rescue experiments using wild-type (WT) alleles.
Main Results:
- Four children with severe VZV infections were identified as heterozygous for rare missense mutations in POLR3A, POLR3C, or both.
- Patient leukocytes showed impaired IFN induction upon stimulation with DNA and defective IFN production and VZV replication control upon VZV infection.
- These cellular phenotypes were reversed by gene correction with WT alleles.
Conclusions:
- Monogenic or digenic deficiencies in POLR3A and POLR3C increase susceptibility to severe VZV disease in healthy children.
- This study highlights the critical role of RNA polymerase III and DNA sensing pathways in innate immunity against VZV.
- Defects in DNA sensing mechanisms represent a novel risk factor for severe VZV infections.
Related Concept Videos
Eukaryotic RNA Polymerases
27.3K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
27.3K
Eukaryotic RNA Polymerases
9.7K
9.7K
Viral Mutations
40.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
Translation
18.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
18.9K
Translation
157.9K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.9K


